US Patent 7601721 Substituted heterocyclic compounds

Patent 7601721 was granted and assigned to Gilead Palo Alto, Inc on October, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Gilead Palo Alto, Inc

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7601721

Date of Patent

October 13, 2009

Patent Application Number

11856712

Date Filed

September 17, 2007

Patent Primary Examiner

Emily Bernhardt

Patent abstract

Disclosed are novel piperazine and piperazine derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, diabetes, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction.